REFERENCES
- Timmer CJ, Mulders TMT. Pharmacokinetics of etonogestrel and ethinylestradiol released from a com- bined contraceptive vaginal ring. Clin Pharmacokinet 2000;39:233–42
- Mulders TMT, Dieben TOM. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 2001;75:865–70
- Mulders TMT, Dieben TOM, Bennink HJT. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod 2002;17:2594–9
- Dieben TOM, Roumen FJME, Apter D. Efficacy, cycle control and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585–93
- Bjarnado´ttir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinylestradiol. Am J Obstet Gynecol 2002;186:389–95
- Wynn V, Adams PW, Godsland I, et al. Comparison of effects of different combined oral-contraceptive formu- lations on carbohydrate and lipid metabolism. Lancet 1979;1(8125):1045–9
- Godsland IF, Crook D, Wynn V. Low-dose oral contraceptives and carbohydrate metabolism. Am J Obstet Gynecol 1990;163:348–53
- van der Vange N, Kloosterboer HJ, Haspels AA. Effect of seven low-dose combined oral contraceptive prepara- tions on carbohydrate metabolism. Am J Obstet Gynecol 1987;156:918–22
- Luyckx AS, Gaspard UJ, Romus MA, et al. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril 1986;45:635–42
- Berga SL. Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette. Am J Obstet Gynecol 1998;179:S9–17
- Shoupe D. Effects of desogestrel on carbohydrate metabolism. Am J Obstet Gynecol 1993;168:1041–7
- Song S, Chen JK, Yang PJ, et al. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Contraception 1992;45:523–32
- Wiegratz I, Kutschera E, Lee JH, et al. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters. Contraception 2003;67:361–6
- Kivela¨ A, Ruuskanen M, A° gren U, et al. The effects of two progestogen-only pills containing either desogestrel (75 mcg/day) or levonorgestrel (30 mcg/day) on carbohydrate metabolism and adrenal and thyroid func- tion. Eur J Contracept Reprod Health Care 2001;6:71–7
- Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990;323:1375–81
- Chez RA. Metabolic aspects of the new low-dose oral contraceptives. Int J Fertil 1989;34(Suppl):50–4
- Spellacy WN. Carbohydrate metabolism during treat- ment with estrogen, progestogen, and low-dose oral contraceptives. Am J Obstet Gynecol 1982;142:732–4
- De Pirro R, Forte F, Bertoli A, et al. Changes in insulin receptors during oral contraception. J Clin Endocrinol Metab 1981;52:29–33
- van der Vange N, Blankenstein MA, Kloosterboer HJ, et al. Effects of seven low-dose combined oral contra- ceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contra- ception 1990;41:345–52
- Hammond GL, Langley MS, Robinson PA, et al. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril 1984;42:44–51
- Jung-Hoffmann C, Kuhl H. Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives. Contraception 1989; 40:299–312
- Hu¨mpel M, Tuber U, Kuhnz W, et al. Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives. Horm Res 1990;33:35–9
- Kuhl H, Gahn G, Romberg G, et al. A randomized cross- over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters. II. Effects upon thyroid function, gastrin, STH, and glucose tolerance. Contraception 1985;32:97–107
- Penttila¨ IM, Makkonen M, Castren O. Thyroid function during treatment with a new oral contraceptive combi- nation containing desogestrel. Eur J Obstet Gynecol Reprod Biol 1983;16:269–74